| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3727442
[patent_doc_number] => 05652122
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Nucleic acids encoding and methods of making tat-derived transport polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/450257
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 34083
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652122.pdf
[firstpage_image] =>[orig_patent_app_number] => 450257
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450257 | Nucleic acids encoding and methods of making tat-derived transport polypeptides | May 24, 1995 | Issued |
Array
(
[id] => 3704290
[patent_doc_number] => 05674980
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Fusion protein comprising tat-derived transport moiety'
[patent_app_type] => 1
[patent_app_number] => 8/450098
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 34115
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674980.pdf
[firstpage_image] =>[orig_patent_app_number] => 450098
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450098 | Fusion protein comprising tat-derived transport moiety | May 24, 1995 | Issued |
Array
(
[id] => 3879070
[patent_doc_number] => 05804604
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Tat-derived transport polypeptides and fusion proteins'
[patent_app_type] => 1
[patent_app_number] => 8/450236
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 26
[patent_no_of_words] => 34250
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804604.pdf
[firstpage_image] =>[orig_patent_app_number] => 450236
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450236 | Tat-derived transport polypeptides and fusion proteins | May 24, 1995 | Issued |
Array
(
[id] => 3879533
[patent_doc_number] => 05747641
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Tat-derived transport polypeptide conjugates'
[patent_app_type] => 1
[patent_app_number] => 8/451233
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 34039
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747641.pdf
[firstpage_image] =>[orig_patent_app_number] => 451233
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451233 | Tat-derived transport polypeptide conjugates | May 24, 1995 | Issued |
Array
(
[id] => 3840507
[patent_doc_number] => 05707835
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Ribozymes'
[patent_app_type] => 1
[patent_app_number] => 8/446884
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 38
[patent_no_of_words] => 11424
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/707/05707835.pdf
[firstpage_image] =>[orig_patent_app_number] => 446884
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446884 | Ribozymes | May 16, 1995 | Issued |
| 08/441141 | EMBEDDED EXPRESSION FO HETEROLOGOUS PROTEINS | May 14, 1995 | Abandoned |
Array
(
[id] => 3666959
[patent_doc_number] => 05668266
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Synthesis of single-stranded labelled oligonucleotides of preselected sequence'
[patent_app_type] => 1
[patent_app_number] => 8/439860
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14463
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/668/05668266.pdf
[firstpage_image] =>[orig_patent_app_number] => 439860
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439860 | Synthesis of single-stranded labelled oligonucleotides of preselected sequence | May 11, 1995 | Issued |
| 08/438379 | INHIBITION OF TRANSCRIPTION FACTOR-MEDIATED TRANSCRIPTIONAL ACTIVATION BY OLIGOMER STRAND INVASION | May 9, 1995 | Abandoned |
Array
(
[id] => 3766801
[patent_doc_number] => 05773244
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Methods of making circular RNA'
[patent_app_type] => 1
[patent_app_number] => 8/431896
[patent_app_country] => US
[patent_app_date] => 1995-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 13936
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773244.pdf
[firstpage_image] =>[orig_patent_app_number] => 431896
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/431896 | Methods of making circular RNA | Apr 30, 1995 | Issued |
Array
(
[id] => 4031368
[patent_doc_number] => 05994314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Compositions and methods for nucleic acid delivery to the lung'
[patent_app_type] => 1
[patent_app_number] => 8/422563
[patent_app_country] => US
[patent_app_date] => 1995-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7007
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994314.pdf
[firstpage_image] =>[orig_patent_app_number] => 422563
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/422563 | Compositions and methods for nucleic acid delivery to the lung | Apr 13, 1995 | Issued |
Array
(
[id] => 4045105
[patent_doc_number] => 05869283
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Expression cassette operable in a recombinant host'
[patent_app_type] => 1
[patent_app_number] => 8/418085
[patent_app_country] => US
[patent_app_date] => 1995-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 69
[patent_no_of_words] => 25302
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869283.pdf
[firstpage_image] =>[orig_patent_app_number] => 418085
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/418085 | Expression cassette operable in a recombinant host | Apr 5, 1995 | Issued |
| 08/417507 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY TO THE LUNG | Apr 3, 1995 | Abandoned |
Array
(
[id] => 4043776
[patent_doc_number] => 05912140
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Recombinant pneumocystis carinii aminoacyl tRNA synthetase genes, tester strains and assays'
[patent_app_type] => 1
[patent_app_number] => 8/415593
[patent_app_country] => US
[patent_app_date] => 1995-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 38709
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912140.pdf
[firstpage_image] =>[orig_patent_app_number] => 415593
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/415593 | Recombinant pneumocystis carinii aminoacyl tRNA synthetase genes, tester strains and assays | Apr 2, 1995 | Issued |
| 08/415381 | METHOD OF MODULATING GENE EXPRESSION WITHOUT DEPLETING COMPLEMENT | Apr 2, 1995 | Abandoned |
Array
(
[id] => 3699838
[patent_doc_number] => 05674683
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Stem-loop and circular oligonucleotides and method of using'
[patent_app_type] => 1
[patent_app_number] => 8/408656
[patent_app_country] => US
[patent_app_date] => 1995-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12976
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674683.pdf
[firstpage_image] =>[orig_patent_app_number] => 408656
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408656 | Stem-loop and circular oligonucleotides and method of using | Mar 20, 1995 | Issued |
Array
(
[id] => 3659052
[patent_doc_number] => 05623070
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Heteroatomic oligonucleoside linkages'
[patent_app_type] => 1
[patent_app_number] => 8/395168
[patent_app_country] => US
[patent_app_date] => 1995-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17128
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/623/05623070.pdf
[firstpage_image] =>[orig_patent_app_number] => 395168
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/395168 | Heteroatomic oligonucleoside linkages | Feb 26, 1995 | Issued |
Array
(
[id] => 3700396
[patent_doc_number] => 05677437
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Heteroatomic oligonucleoside linkages'
[patent_app_type] => 1
[patent_app_number] => 8/392675
[patent_app_country] => US
[patent_app_date] => 1995-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32136
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 545
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677437.pdf
[firstpage_image] =>[orig_patent_app_number] => 392675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392675 | Heteroatomic oligonucleoside linkages | Feb 22, 1995 | Issued |
| 08/380650 | HUMAN IMMUNODEFICIENCY VIRUS TRANSCRIPTION INHIBITORS AND METHODS OF THEIR USE | Jan 29, 1995 | Abandoned |
Array
(
[id] => 3941343
[patent_doc_number] => 05872241
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Multiple component RNA catalysts and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/378235
[patent_app_country] => US
[patent_app_date] => 1995-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 14161
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/872/05872241.pdf
[firstpage_image] =>[orig_patent_app_number] => 378235
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/378235 | Multiple component RNA catalysts and uses thereof | Jan 24, 1995 | Issued |
Array
(
[id] => 3869310
[patent_doc_number] => 05763268
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Hepatitis delta virus compositions and expression vectors'
[patent_app_type] => 1
[patent_app_number] => 8/370546
[patent_app_country] => US
[patent_app_date] => 1995-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5913
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763268.pdf
[firstpage_image] =>[orig_patent_app_number] => 370546
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/370546 | Hepatitis delta virus compositions and expression vectors | Jan 8, 1995 | Issued |